Application of chlorophyll and/or derivatives thereof in preparing medicine for preventing and/or treating iron overload

A technology of chlorophyll and derivatives, which is applied in the field of medicine, can solve the problems of short half-life of deferoxamine, high cost of treatment, and limited use of people, achieve significant curative effect, improve iron deficiency anemia, and avoid excessive iron removal treatment.

Inactive Publication Date: 2017-07-28
武汉联合药业有限责任公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Although iron chelation therapy has achieved certain curative effect, its disadvantages are as follows: (1) Adverse reactions are obvious and numerous, including ocular and ear toxicity, growth retardation, bone changes, granulocyte and leukopenia, gastrointestinal dysfunction, digestive tract Hemorrhage, liver and kidney failure, etc.; (2) Water-soluble, so that it cannot enter cells to transfer a large amount of iron bound to transferrin; (3) Desferrioxamine has a short half-life (20-30min), requiring long-term subcutaneous or intravenous injection, and poor compliance ; ⑷The treatment cost is expensive, for example, the price of Orbeanco brand deferiprone tablets is 680 yuan / bottle (30 tablets), adults need to take 3 times a day, 3 tablets each time, and the daily drug price is 204 yuan; ⑸ Use The population is limited, the elderly, pregnant women, lactating women and children under 6 years old should not use it or use it with caution

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of chlorophyll and/or derivatives thereof in preparing medicine for preventing and/or treating iron overload
  • Application of chlorophyll and/or derivatives thereof in preparing medicine for preventing and/or treating iron overload
  • Application of chlorophyll and/or derivatives thereof in preparing medicine for preventing and/or treating iron overload

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Embodiment 1. Preparation of chlorophyll extract (containing chlorophyll and its derivatives)

[0035] Put the silkworm excrement in an ultra-micro vibrating mill, add 70% to 80% ethanol, extract for 2-5 minutes, then add 70% to 80% ethanol to extract for 5-15 minutes, discharge the material, and separate the supernatant by centrifugation liquid and dregs, the supernatant was recycled to ethanol to obtain crude extracts of chlorophyll and its derivatives. Rinse the crude chlorophyll extract with deionized water for 1-3 times, filter, and the resulting filter residue is the fine extract of chlorophyll and its derivatives. Dissolve the chlorophyll extract with No. 120 gasoline, add a sufficient amount of NaOH solution, stir to make it fully saponified, and take the lower layer of saponified liquid. Adjust the pH value of the saponification solution to 2-4 with acid solution, dissolve the precipitated precipitate in acetone or 95% ethanol, then add enough NaOH ethanol sol...

Embodiment 2

[0036] Example 2. The effect of removing iron from chlorophyll extract (containing chlorophyll and its derivatives)

[0037] 80 Kunming mice were randomly divided into normal control group, positive control group, high-dose chlorophyll group and low-dose chlorophyll group, with 20 mice in each group, half male and half male. Except for the normal group, mice in other groups were injected intraperitoneally with iron dextran once a week at 100 mg / kg for 10 consecutive weeks to establish the iron overload mouse model. From the day of modeling, each group was given intragastric administration once a day, of which: the normal control group was given 1ml of normal saline, the positive control group was given 1ml of normal saline, and the high-dose chlorophyll extract group was given 80 mg / kg of chlorophyll extract aqueous solution 1ml, the chlorophyll extract low-dose group was given 1ml of chlorophyll extract aqueous solution at 40mg / kg, and after the treatment, the blood was taken...

Embodiment 3

[0059] Example 3. The clinical iron removal effect of chlorophyll extract (containing chlorophyll and its derivatives) and deferasirox in combination

[0060] In order to prove the therapeutic effect of the combined use of chlorophyll and its derivatives and deferasirox, patients with iron overload were given chlorophyll tablets containing chlorophyll and its derivatives and deferasirox tablets for observation.

[0061] ⑴ General information

[0062] A total of 32 patients with iron overload caused by long-term blood transfusion due to various anemias were selected, including 18 males and 14 females, aged 18-68 years, including 16 cases of severe aplastic anemia (SAA), 10 cases of thalassemia major, Dysplastic syndrome (MDS) in 6 cases, the liver and kidney functions were normal before treatment. They were randomly divided into a control group (16 cases) and a treatment group (16 cases). When the SF level of the patients exceeded 1000 μg / L, iron-removing treatment was given. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to application of chlorophyll and / or derivatives thereof in preparing medicine for preventing and / or treating iron overload. The invention further relates to a combination of the chlorophyll and / or the derivatives thereof and an iron chelating agent for preventing and / or treating iron overload. The chlorophyll and / or the derivatives thereof can improve iron-deficiency anemia, lower in-vivo iron content and avoid excessive iron chelation and has no obvious side effect. Treatment effect of the iron chelating agent can be improved by combining the chlorophyll and / or the derivatives thereof with the iron chelating agent, so that treatment period when the iron chelating agent is used solely can be shortened, risk of generating adverse reaction caused by long-time administration of the iron chelating agent is lowered, and economic burden of patients is relieved substantially.

Description

technical field [0001] The present invention relates to the use of chlorophyll and / or its derivatives, in particular to the use of chlorophyll and / or its derivatives for preventing and / or treating iron overload, and belongs to the field of medicine. Background technique [0002] Iron overload, also known as iron overload, is when the body's iron supply exceeds iron demand. There are many reasons for the formation of iron overload. For example, the body takes in too much iron due to oral iron, injection of iron, blood transfusion, etc.; another example, gene mutation, drinking, virus infection, etc. lead to disturbance of liver regulation of iron balance; another example, Inherited or acquired iron metabolism abnormalities, etc.; in addition, certain diseases can also affect the metabolism of iron in the microenvironment, resulting in the selective deposition of iron in specific cells, such as viral hepatitis, which causes iron to be deposited in liver cells, resulting in iro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/409A61P7/06A61P3/12
CPCA61K31/409
Inventor 刘朝胜周红晖吴瑜罗京徐发新刘磊
Owner 武汉联合药业有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products